News & Updates

Children with homozygous familial hypercholesterolaemia (HoFH) achieve significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) with the microsomal triglyceride transfer protein (MTP) inhibitor lomitapide, which represents an efficient LDL receptor-independent treatment option, according to the open-label phase III APH-19 trial.

Drinking 2 to 3 cups of black coffee daily appears protective against metabolic syndrome (MetS) in women, potentially due to its positive impact on high-density lipoprotein cholesterol (HDL-C) and triglycerides, suggests a Korea study.

For patients with heart failure (HF), hyperuricaemia is a risk factor for an increase in the risk of short-term hospital readmission and mortality, as reported in a retrospective study.

A Singapore hospital has pioneered a tailored peritoneal dialysis (PD) training program that has yielded a significant reduction in PD-related infections and dropouts among patients with end-stage kidney disease (ESKD).

Electrolyte abnormalities within 1 year of eating disorder diagnosis are associated with an increased risk of all-cause mortality, a population-based study in Canada has shown.

The proportion of Hong Kong’s population with cardiovascular-kidney-metabolic (CKM) syndrome has increased from 87.8 percent 20 years ago to 90.8 percent in 2024, an ongoing population-based, cross-sectional study of cardiovascular (CV) risk factors and disease prevalence in Hong Kong Chinese (N-CRISPS) has found.

Patients with heterozygous familial hypercholesterolaemia do not appear to be protected against type 2 diabetes (T2D), which markedly increases in the presence of obesity, according to a worldwide cross-sectional study.

Fathers who use metformin during the period of sperm development does not seem to contribute to congenital malformations in their children, a study has shown.